Lucira Health, Inc. (LHDX)
| Market Cap | 217.17M |
| Revenue (ttm) | 4.79M |
| Net Income (ttm) | n/a |
| Shares Out | 22.89M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 11 |
| Last Price | $5.63 |
| Previous Close | $5.31 |
| Change ($) | 0.32 |
| Change (%) | 6.03% |
| Day's Open | 5.80 |
| Day's Range | 5.41 - 5.88 |
| Day's Volume | 693,982 |
| 52-Week Range | 4.23 - 37.99 |
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
This start-up's over-the-counter COVID-19 tests could be a huge hit.
EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercia...
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...
EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of tr...
This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO.
EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of ...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
This analyst thinks the company's stock performance will trail that of the market.
The company's COVID-19 Test Kit will soon be available for sale at a pharmacy near you.
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
After the sell-off in February, the markets have sprung back up. The broader S&P 500 Index is trading at an all-time high and the blue-chip Dow Jones Industrial Index is just shy of its all-time peak.
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), today announced that U.S. physicians and healthcare providers can now order Lucira COVID-19 All-In-One Test Kits online from luci...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative inf...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative inf...
Lucira Health, which is developing single-use test kits for COVID-19 and other infectious diseases, filed on Friday with the SEC to raise up to $115 million in an initial public offering.
Lucira Health, Inc. has filed to go public with an IPO on the NASDAQ.
Amid surging coronavirus cases, the top U.S. testing official on Thursday announced another scale-up in the country’s diagnostic efforts, touting the importance of tests that can run from start to finis...
About LHDX
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. We have developed a testing platform that produces centralized-laboratory-accurate molecular testing in a single-use and consumer-friendly test kit that is powered by two AA batteries and fits in the palm of a hand. We designed our test kits to provide accurate, reliable and on-the-spot molecular test results anywhere and at any time. Our LUCIRA COVID-19 All-In-One Test Kit, or our COVID-1... [Read more...]
| Industry Diagnostics & Research | IPO Date Feb 5, 2021 |
| CEO Erik T. Engelson | Employees 71 |
| Stock Exchange NASDAQ | Ticker Symbol LHDX |
Analyst Forecasts
The average 12-month stock price forecast for Lucira Health is 8.50, which is an increase of 50.98% from the latest price.